# CPG Sec  490100 Process Validation Requirements for Drug Products and Active Pharmaceutical Ingredients Subject to Pre-Market Approval - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/compliance-policy-guide-cpg/cpg-sec-490100-process-validation-requirements-for-drug-products-and-active-pharmaceutical-ingredients-subject-to-pre-market-approval/864a062a-ddcb-4710-b694-d588ace094c0

> FDA guidance document: CPG Sec  490100 Process Validation Requirements for Drug Products and Active Pharmaceutical Ingredients Subject to Pre-Market Approval. Issue date: March 12, 2004. Get complete insights and analysis.

---

## Details

- Title: CPG Sec  490100 Process Validation Requirements for Drug Products and Active Pharmaceutical Ingredients Subject to Pre-Market Approval
- Communication Type: Compliance Policy Guide (CPG)
- Product Type: drugs
- Office Name: Office of Regulatory Affairs
- Office URL: /offices/office-of-regulatory-affairs/ff91c598-cf72-4dbe-a2c8-7519c64cbc64
- Issue Date: 2004-03-12
- Last Changed: 2018-12-01

## Related Documents

- [CPG Sec 335700 Surgeons' Gloves and Patient Examination Gloves; Defects - Criteria for Direct Reference Seizure](https://www.globalkeysolutions.net/guidances/compliance-policy-guide-cpg/cpg-sec-335700-surgeons-gloves-and-patient-examination-gloves-defects-criteria-for-direct-reference-seizure/dc5fbf7d-82f7-4d88-b5d9-26a19906eb3e)
- [CPG Sec 570425 Tree Nuts - Adulteration Involving Rejects (Insect Infestation, Moldy, Rancid, Otherwise Decomposed, Blanks, and Shriveled)](https://www.globalkeysolutions.net/guidances/compliance-policy-guide-cpg/cpg-sec-570425-tree-nuts-adulteration-involving-rejects-insect-infestation-moldy-rancid-otherwise-decomposed-blanks-and-shriveled/d6f87baa-8b59-412a-866f-3382112978e7)
- [CPG Sec 490100 Process Validation Requirements for Drug Products and Active Pharmaceutical Ingredients Subject to Pre-Market Approval](https://www.globalkeysolutions.net/guidances/guidance-document/cpg-sec-490100-process-validation-requirements-for-drug-products-and-active-pharmaceutical-ingredients-subject-to-pre-market-approval/b94c2509-66e7-4f39-b0f9-fad032bc48c3)